Biotech Value Stocks Climb Out of Their Sick Bed

📆 2/11/2019 10:30 p. m.
📰 WSJ

⏱ Reading Time:
17 sec. here
2 min. at publisher
📊 Quality Score:
News: 10%
Publisher: 63%

Colombia Noticias Noticias

Colombia Últimas Noticias,Colombia Titulares

Heard on the Street: Recent good news from Biogen and Bristol-Myers Squibb bolsters hope that years of weak performance may be ending

The biotechnology universe is divided into two groups.

The majority are companies without profits, or even sales, chasing a scientific breakthrough and the resulting massive payoff for investors. A much smaller group of companies have graduated to megacap status. Like most companies of their size, these sport massive profits and cash flows, with much less growth potential.

Escribir Comentario

No, you are correct🧡

I guess that could happen))😀

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Colombia Últimas Noticias, Colombia Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Berkshire Hathaway’s Quarterly Earnings Fell as Unrealized Investment Gains DeclinedWarren Buffett’s Berkshire Hathaway said third-quarter earnings fell as unrealized investment gains declined but operating earnings climbed In other words...he made money. Bail! There are plenty of other choices. It's a pity, but no better idea.
Fuente: WSJ - 🏆 98. / 63 Leer más »